Literature DB >> 12145255

Twenty-four hour action of insulin glargine (Lantus) may be too short for once-daily dosing: a case report.

Stephen Clement, Hazel Bowen-Wright.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12145255     DOI： 10.2337/diacare.25.8.1479-a

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  3 in total

1.  Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics.

Authors:  Jean-Pierre Le Floch
Journal:  Diabetes Metab Syndr Obes       Date:  2010-06-21       Impact factor: 3.168

2.  Diabetes mellitus: Exploring the challenges in the drug development process.

Authors:  Julius A Vaz; Ashis Patnaik
Journal:  Perspect Clin Res       Date:  2012-07

3.  Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study.

Authors:  Li Wang; Wenhui Wei; Raymond Miao; Lin Xie; Onur Baser
Journal:  BMJ Open       Date:  2013-04-30       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.